citic construction investment medical health hybrid securities investment fund (hereinafter referred to as: citic construction investment medical health a, code 010090) announced the latest net value on September 11, up 4.84.

CITIC Jiantou Pharmaceutical Health A was established on September 24, 2020, and the performance benchmark is CSI Medical and Health Index yield x 70% + CSI Composite Bond Index yield x 30%. The fund has gained -32.87 per cent since its inception, -20.28 per cent this year, 2.82 per cent in the past month and -21.67 per cent in the past year. For nearly a year, the fund ranked 5374/6534 in its class.

The fund manager is Xie Wei. Xie Wei has managed (or intends to manage) the fund since September 1, 2020, with a gain of -32.87 during his tenure.

According to the latest periodic report, the top ten stocks of the fund are as follows:

/tr>

Stock Code	Stock Name	Position Percentage		Market value of positions (yuan)
	600276	Hengrui Medicine	8.64	725000	34.7275 million
688617			6.51	70000	26.1625 million
688235	6.31	232500	25.3681 million
688301	yerui technology	5.27	75000	21.1823 million
300633	open medical treatment	4.75	350000	19.075 million
<603456	Jiuzhou Pharmaceutical	4.70	690000	18.8922 million
603658	Anto Bio		4.51%	350000	18.1055 million
688016	Cardiac Medicine	4.48%	100000	17.988 million/td>
	688076		4.43	500000	17.79 million
002422	<4.43>		600000	17.808 million

Now I will give you a red envelope of 60 yuan, direct cash withdrawal is not routine. Please participate in the activity to receive it.